Matt Thomas is Vice President and General Manager for Medtronic’s Pain Stimulation & Early Interventions business. In this role, Matt was instrumental in the launch of IntellisTM, the world’s smallest implantable neurostimulator. Intellis provides patients access to high-dose (HD) and low-dose (LD) therapy for long-term pain relief.
Matt joined Medtronic in 2002 as a product manager for deep brain stimulation. In 2005, he moved to the Diabetes business to work on the global launch of the first sensor enabled insulin pump.
He joined Spine in 2010 as vice president of market development and education, later taking leadership of the Interventional Spine business including marketing, business development, U.S. sales, and research and development.
He won Medtronic’s Marketing Excellence Award in 2005 and has earned multiple healthcare industry awards. He has been a keynote speaker at more than 15 strategy and marketing conferences.